In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by...

Area of Science:

• Cardiology
• Metabolic Diseases
• Molecular Biology

Background:

• Green tea catechins are known to positively influence mitochondrial function.
• Diabetic hearts exhibit altered gene expression and signaling pathways.
• Green tea extract (GTE) may offer cardioprotective benefits in diabetes.

Purpose of the Study:

• To evaluate the effectiveness of standardized green tea extract (GTE) in restoring cardiac performance in a rat model of early diabetes.
• To investigate the underlying molecular mechanisms of GTE's cardioprotective effects.

Main Methods:

• A rat model of streptozotocin-induced diabetes was used.
• Diabetic rats received daily GTE administration for 28 days.
• Cardiomyocyte function, calcium transients, and molecular markers were analyzed.

Main Results:

• GTE treatment nearly normalized cardiomyocyte contractility impaired by diabetes.
• GTE preserved mitochondrial function and cellular energy levels.
• GTE modulated sarcoplasmic reticulum calcium ATPase and phospholamban expression, with Sirtuin 1 (SIRT1) playing a key role.

Conclusions:

• Green tea polyphenols, via SIRT1 targeting, show potential as an adjuvant therapy.
• GTE can counteract early-stage diabetic heart damage before the onset of diabetic cardiomyopathy.